Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the detailed record of transactions filed by Wikler Matthew, Director. Officer active across 1 company, notably Matinas BioPharma Holdings, Inc.. Aggregated, 4 filings have been recorded. History available since 19 June 2021. The latest transaction was disclosed on 31 December 2021 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations
Matthew Wikler is a Board Member at Matinas BioPharma Holdings, Inc. He contributes to overseeing the company's activities and strategic decision-making. His experience in the pharmaceutical sector allows him to provide valuable insights to the board.